Please login to the form below

Not currently logged in

Onyx Health wins OLM Diagnostics account

Will develop a marketing strategy for the UK-based firm

GSK starts trial of Nucala to seek alternate indications

GSK - logo on buildingAsthma therapy drug to be used to target severe nasal polyposis

Merck's anacetrapib rescued by positive phase III trial

Merck and Co - US headquartersData suggests drug reduces MACE compared to placebo

No deal for Stada as private equity takeover bid collapses

Stada flags65.52% of investors supported the takeover, just shy of the 67.5% needed to close the deal

Sanofi and Regeneron bag EU approval for arthritis drug Kevzara

Sanofi receptionThe IL-6 inhibitor will be used in combination with methotrexate for adults with RA

Europe delays EMA relocation decision

European Medicines Agency (EMA) - logoWill resolve the issue in November, one month later than expected

Samsung Bioepis wins CHMP nod for second Humira biosimilar

In addition to Imraldi the regulatory advisors also backed new medicines from AbbVie and Gilead

Merck gets CHMP backing for long-delayed oral MS drug

Merck KGaACladribine, which will be branded as Mavenclad, was originally rejected by the committee in 2010

Healthcare communications to journalists “on life support”

Only 2% of journalists surveyed find information provided by pharma 'trustworthy'

smart solutionsSmart solutions

How technology could help pharma breathe new life into branded respiratory drugs

Latest appointments

Featured jobs

Subscribe to our email news alerts


Add my company

Reaching your audiences, wherever they are. Ashfield is an international provider of outsourcing solutions to the pharmaceutical industry, dedicated to...

Latest intelligence

The Devil is in the E-Detail
All too often, pharma companies are relying on the e-detailing approach, and missing a big opportunity to engage with their customers, build relationships, and add value....
Medical Translations: Why you need to get it right the first time
British and American senior medical executives admit to image and reputation being at risk because of misinterpreted cultural references or linguistic errors....
Digital disruption
How pharma is keeping up with the pace of change...